Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Nic Lochlainn, Laura Mde Gier, Brechje
van der Maas, Nicoline
van Binnendijk, Rob
Strebel, Peter M
Goodman, Tracey
de Melker, Hester E
Moss, William J
Hahné, Susan J M
Language
en
Metadata
Show full item recordTitle
Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis.Published in
Lancet Infect Dis 2019; 19(11):1246-54PMID
31548081ae974a485f413a2113503eed53cd6c53
10.1016/S1473-3099(19)30396-2
Scopus Count
Collections
Related articles
- Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis.
- Authors: Nic Lochlainn LM, de Gier B, van der Maas N, Strebel PM, Goodman T, van Binnendijk RS, de Melker HE, Hahné SJM
- Issue date: 2019 Nov
- Effect of early measles vaccination on long-term protection: A systematic review.
- Authors: Xu J, Doyon-Plourde P, Tunis M, Quach C
- Issue date: 2021 May 21
- Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.
- Authors: Carazo S, Billard MN, Boutin A, De Serres G
- Issue date: 2020 Mar 29
- Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
- Authors: Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM
- Issue date: 2004 Jul 1
- Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.
- Authors: Gans HA, Yasukawa LL, Sung P, Sullivan B, DeHovitz R, Audet S, Beeler J, Arvin AM
- Issue date: 2013 Feb 15